Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
‘Remarkable’ Weight Loss With Novel Oral Combo in Phase 1
MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants with overweight or obesity according to phase 1, first-in-human study data presented at the European Association for the Study of…
English